What analysts say about VVOS stock - High-octane financial growth - jammulinksnews.com
14 hours ago • Google News
Vivos Therapeutics Inc (VVOS)
US$ 2.63-2.95%
Price Chart
Key Statistics
Market Cap
$ 34.28M
P/E Ratio
0.00
Revenue (TTM)
$ 14.63M
Volume
54.13K
52W High
$ 7.95
52W Low
$ 1.97
Dividend Yield
0.00%
Beta
6.99
Technicals
50-Day MA
3.3561
200-Day MA
3.407
52 Week High
7.95
52 Week Low
1.97
About VVOS
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and .
Employees
113
Headquarters
Littleton, CO
CEO
Mr. R. Kirk Huntsman
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg